CCCA’s Analysis of the TOGETHER Trial’s Ivermectin Arm Results

CCCA’s Analysis of the TOGETHER Trial’s Ivermectin Arm Results

The CCCA has completed its analysis of the ivermectin arm of the TOGETHER trial (published in the New England Journal of Medicine (NEJM) on March 30th 2022; Effect of Early Treatment with Ivermectin among Patients with Covid-19). This high-profile trial sought to evaluate the potential of repurposing multiple previously established medications for the management of COVID-19. We have identified numerous issues with the study protocol and analysis which raise deep concerns about the publicized conclusions of the trial’s ivermectin arm.

Recommended citation: Halgas, O. (2022) Analysis of the TOGETHER Trial’s Ivermectin Arm Results. Canadian Covid Care Alliance. April 28, 2022. https://canadiancovidcarealliance.org/media-resources/analysis-together-ivermectin-trial/

Share on facebook
Share on twitter
Share on linkedin
Share on email

Related Posts

D’ARRÊTER LES INJECTIONS

Nous pensons qu’à ce stade de la crise COVID-19, les risques associés aux vaccins à ARNm COVID-19 dépassent de loin les avantages pour les enfants.